Published on
Jul 24, 2025
FDA Approves Delgocitinib, First Treatment for Adults with Moderate to Severe Chronic Hand Eczema
The FDA on Wednesday approved delgocitinib (Anzupgo) cream 20 mg/g for the topical treatment of moderate-to-severe chronic hand eczema (CHE) in adults who have had an inadequate response to, or for whom topical corticosteroids are not advisable, …
Source:
Patient Care
-
Pending
